151 related articles for article (PubMed ID: 23530909)
1. Immunohistochemical expression of glypican-3 in pediatric tumors: an analysis of 414 cases.
Chan ES; Pawel BR; Corao DA; Venneti S; Russo P; Santi M; Sullivan LM
Pediatr Dev Pathol; 2013; 16(4):272-7. PubMed ID: 23530909
[TBL] [Abstract][Full Text] [Related]
2. Claudin-6 is a nonspecific marker for malignant rhabdoid and other pediatric tumors.
Sullivan LM; Yankovich T; Le P; Martinez D; Santi M; Biegel JA; Pawel BR; Judkins AR
Am J Surg Pathol; 2012 Jan; 36(1):73-80. PubMed ID: 21989342
[TBL] [Abstract][Full Text] [Related]
3. Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas.
Thway K; Selfe J; Missiaglia E; Fisher C; Shipley J
J Clin Pathol; 2011 Jul; 64(7):587-91. PubMed ID: 21493758
[TBL] [Abstract][Full Text] [Related]
4. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases.
Zynger DL; Gupta A; Luan C; Chou PM; Yang GY; Yang XJ
Hum Pathol; 2008 Feb; 39(2):224-30. PubMed ID: 17949790
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
6. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression.
Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y
Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579
[TBL] [Abstract][Full Text] [Related]
7. Glypican 3 expression in pediatric malignant solid tumors.
Kinoshita Y; Tanaka S; Souzaki R; Miyoshi K; Kohashi K; Oda Y; Nakatsura T; Taguchi T
Eur J Pediatr Surg; 2015 Feb; 25(1):138-44. PubMed ID: 25344940
[TBL] [Abstract][Full Text] [Related]
8. Glypican 3: a novel marker in testicular germ cell tumors.
Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
[TBL] [Abstract][Full Text] [Related]
9. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3: a useful biomarker for differential diagnosis of brain tumors.
Park SH; Min HS; Kim B; Myung J; Paek SH
Neuropathology; 2008 Oct; 28(5):497-506. PubMed ID: 18384511
[TBL] [Abstract][Full Text] [Related]
11. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.
Veugelers M; Vermeesch J; Watanabe K; Yamaguchi Y; Marynen P; David G
Genomics; 1998 Oct; 53(1):1-11. PubMed ID: 9787072
[TBL] [Abstract][Full Text] [Related]
12. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
13. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of CRX in extracranial malignant small round cell tumors.
Terry J; Calicchio ML; Rodriguez-Galindo C; Perez-Atayde AR
Am J Surg Pathol; 2012 Aug; 36(8):1165-9. PubMed ID: 22790857
[TBL] [Abstract][Full Text] [Related]
15. Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study.
Zhang L; Liu H; Sun L; Li N; Ding H; Zheng J
Acta Histochem; 2012 Oct; 114(6):547-52. PubMed ID: 22119409
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors.
Ortiz MV; Roberts SS; Glade Bender J; Shukla N; Wexler LH
Front Oncol; 2019; 9():108. PubMed ID: 30873384
[TBL] [Abstract][Full Text] [Related]
17. The Simpson-Golabi-Behmel gene, GPC3, is not involved in sporadic Wilms tumorigenesis.
Gillan TL; Hughes R; Godbout R; Grundy PE
Am J Med Genet A; 2003 Sep; 122A(1):30-6. PubMed ID: 12949968
[TBL] [Abstract][Full Text] [Related]
18. Expression of glypican 3 (GPC3) in embryonal tumors.
Saikali Z; Sinnett D
Int J Cancer; 2000 Sep; 89(5):418-22. PubMed ID: 11008203
[TBL] [Abstract][Full Text] [Related]
19. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
[TBL] [Abstract][Full Text] [Related]
20. A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family.
Xuan JY; Hughes-Benzie RM; MacKenzie AE
J Med Genet; 1999 Jan; 36(1):57-8. PubMed ID: 9950367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
